SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 82.35-4.5%Jan 8 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (143)2/20/2003 1:51:26 PM
From: Jibacoa   of 3722
 
DNDN Is up 7.87% on volume of 164K, still below 2x its daily average. The price, at last trade, is 6.72 (it traded at 7.20 at 9.55AM)

DNDN will present new data from its recently completed Phase III of Provenge for treatment of prostatic Ca., on Sunday, February 23, at the 13th International Prostate Cancer Update meeting in Vail, Colorado. (The report will include data from a patient who had a complete response and experienced a durable remission.)

The stock is trading above its Dec.5 H of 6.33

siliconinvestor.com

Will see how much help the stock can get with the scheduled "presentations".<g>

It still has to close above its April 2002 H of 7.19 before it can test the Jan.11,2001 H at 9.75 and the Jan.4 H at 11.22(The June 2001 H at 18 is too far away at present.<g>)

siliconinvestor.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext